Development of a microdilution method to evaluate Mycobacterium tuberculosis drug susceptibility.
about
Phenotypic and genomic comparison of Mycobacterium aurum and surrogate model species to Mycobacterium tuberculosis: implications for drug discovery.Anti tuberculosis drug resistance in west of iran.Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS familiesPhytochemical analysis and antibacterial evaluation of the ethyl acetate extract of the stem bark of Bridelia micrantha.Lanostane- and cycloartane-type triterpenoids from Abies balsamea oleoresinGeneral Toxicity and Antifungal Activity of a New Dental Gel with Essential Oil from Abies Sibirica L.A systematic review of rapid drug susceptibility tests for multidrug-resistant tuberculosis using rifampin resistance as a surrogate.Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study.Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis.Diterpenoids from the buds of Pinus banksiana Lamb.Susceptibilities of Mycobacterium tuberculosis to isoniazid and rifampin on blood agar.The resazurin microplate method for rapid detection of vancomycin resistance in enterococci.PdtaS Deficiency Affects Resistance of Mycobacteria to Ribosome Targeting Antibiotics.In vivo virulence of Mycobacterium tuberculosis depends on a single homologue of the LytR-CpsA-Psr proteins.Comparative study of composition and biological activities of SDE prepared essential oils from flowers and fruits of two Hypericum species from central Iran.
P2860
Q33901126-8CA01127-60F7-42D9-A5F0-F4C85BB628E4Q34101408-065CF1A3-9CAF-48C7-9133-B4A9C8B5872CQ35995070-46FE600F-9ED3-4D5A-8EC2-2EBF82C1A44AQ36825095-AFF4EB2F-9985-4817-B755-6543DE60EF67Q37088504-85F46030-2275-453E-97D8-496245B7CC3DQ37628568-E9DC1DC9-8FBA-4BEC-BE82-6266047994C1Q38088848-9B2B60F5-2D9C-4188-945F-463D0F20F1F0Q38929849-0F52D1C1-B4D1-470C-998D-814EDF1FD6E6Q39264526-0B9412DF-FF0A-4A29-BE76-E539942C91D6Q39298060-B753246A-0A90-4260-A601-84FAAE6F518CQ41976804-89D2A73D-95E8-4530-8147-B65E7481A9D8Q46707111-0694CA2B-1A52-4820-9B86-091E78E643A6Q47147218-2C4993AA-D6B7-4755-89FB-BF5CA9CC7545Q52368820-9C3E50C1-ECBE-493E-812E-220A03B35A40Q54355234-8EE205D9-51F0-4AD1-9336-1BA70D85461F
P2860
Development of a microdilution method to evaluate Mycobacterium tuberculosis drug susceptibility.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Development of a microdilution ...... erculosis drug susceptibility.
@en
Development of a microdilution ...... erculosis drug susceptibility.
@nl
type
label
Development of a microdilution ...... erculosis drug susceptibility.
@en
Development of a microdilution ...... erculosis drug susceptibility.
@nl
prefLabel
Development of a microdilution ...... erculosis drug susceptibility.
@en
Development of a microdilution ...... erculosis drug susceptibility.
@nl
P2093
P356
P1476
Development of a microdilution ...... erculosis drug susceptibility.
@en
P2093
Carlo Monti-Bragadin
Elena Banfi
Giuditta Scialino
P304
P356
10.1093/JAC/DKG439
P407
P577
2003-09-30T00:00:00Z